EP0000988B1 - Demand cardiac stimulating apparatus - Google Patents

Demand cardiac stimulating apparatus Download PDF

Info

Publication number
EP0000988B1
EP0000988B1 EP19780300242 EP78300242A EP0000988B1 EP 0000988 B1 EP0000988 B1 EP 0000988B1 EP 19780300242 EP19780300242 EP 19780300242 EP 78300242 A EP78300242 A EP 78300242A EP 0000988 B1 EP0000988 B1 EP 0000988B1
Authority
EP
European Patent Office
Prior art keywords
counter
input
reset
counter means
interval
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
EP19780300242
Other languages
German (de)
French (fr)
Other versions
EP0000988A1 (en
Inventor
Dennis Digby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotronik SE and Co KG
Original Assignee
Biotronik Mess und Therapiegeraete GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/917,129 external-priority patent/US4173230A/en
Application filed by Biotronik Mess und Therapiegeraete GmbH and Co filed Critical Biotronik Mess und Therapiegeraete GmbH and Co
Publication of EP0000988A1 publication Critical patent/EP0000988A1/en
Application granted granted Critical
Publication of EP0000988B1 publication Critical patent/EP0000988B1/en
Expired legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential

Definitions

  • This invention relates to implantable body function control apparatus and particularly, to body tissue stimulating devices in the form of cardiac pacemakers.
  • Pacemakers for generating artificial stimulating pulses for the heart, and which may or may not be implanted in the body, are well-known. Pacemakers can be classified into demand and non-demand types. A demand pacemaker only issues an artificial pulse if the heart does not produce its own satisfactory natural beat, whereas a non-demand pacemaker issues artifical stimulating pulses without regard to the presence or absence of a natural beat.
  • a demand pacemaker normally includes an input amplifier for receiving and amplifying electrical signals from the heart (which signals might result from either a natural beat or an artificial pulse which has just been generated by the pacemaker), a pacemaker control circuitry which receives the amplified signals and which causes a new artificial stimulating pulse to be generated (for transmission to the heart) only if the amplified signals, or lack thereof, show that an artifical stimulating pulse is required by the heart (i.e. on demand), and an output amplifier which receives and amplifies the artifical pulses generated by the control circuitry, for passage to the heart.
  • pacemaker control circuitry as described above are available. Some function on an analog basis to produce the accurately- timed artifical stimulating pulses, whereas several recent designs employ digital circuitry.
  • Noise protection circuits have been incorporated into demand pacemakers in the past. For example, several include filters to attenuate noise signals of particular frequencies (particularly the commercial power mains frequency).
  • one cardiac pacer affording a form of noise protection is known from French Patent Publication No. 2,329,007.
  • this protection only extends to noise signals received within the refractory period. If a disturbance signal with pulse intervals below a predetermined minimum interval commences after the end of the refractory period this is liable to erroneous evaluation as a signal arising due to the unaided action of the heart.
  • U.S. Patent No. 3,557,796 discloses a cardiac pacer in which a counter driven by an oscillator can be reset under certain conditions by ventricular or atrial input signals. Noise signals are detected before the period during which the pacer is sensitive to said input signals and, if such noise signals are detected, bring a noise protection circuit into operation. However, if a disturbance signal is initiated only very shortly before the sensitive period of the pacer, the number of noise pulses required for triggering the noise protection circuit is not attained.
  • a demand cardiac stimulating apparatus comprising:
  • the pacemaker comprises an oscillator 1 which clocks a ripple counter 2.
  • a cardiac stimulating pulse rate is obtained from an approriate output stage, Q, of counter 2 and is provided to an output amplifier 3 and to one input of an OR gate 4.
  • the output amplifier 3 provides amplified tissue stimulating pulses to a connection 5 for coupling to an electrode leading to the heart.
  • the output of OR gate 4 is supplied to a monostable 6, which is employed to reset counter 2.
  • the pacemaker also includes an input amplifier 8 which receives electrical signals generated at the heart (e.g. arising from natural heart beats) and supplies these signals, amplified, to the reset input of a ripple counter 9.
  • an input amplifier 8 which receives electrical signals generated at the heart (e.g. arising from natural heart beats) and supplies these signals, amplified, to the reset input of a ripple counter 9.
  • NAND gate 10 Two of the output stages of counter 9, nominated 03 and Q4 provide inputs to a NAND gate 10, the output of which supplies the clock input to a D-type flip-flop 11 and an input to a NAND gate 12. The latter clocks ripple counter 9.
  • the Q output of flip-flop 11 supplies a second input to OR gate 4, and the D-input of flip-flop 11 is tied to the positive supply rail.
  • a further D-type flip-flop 13 is provided which is reset from the output monostable 6 and whose Q output is employed to reset flip-flop 11.
  • the D-input of flip-flop 13 is tied to the positive supply rail.
  • the counter 2 also supplies two clock outputs, CK, and CK z .
  • CK having a period of 8 msecs, is employed to provide a second input to NAND gate 12, and CK 2 is employed to clock flip-flop 13.
  • the clock pulse CK 2 arises 320 msecs after counter 2 is reset.
  • the pacemaker operates as follows. In its fixed rate mode, with neither noise nor natural heart beats being detected and amplified by input amplifier 8, counter 2 issues a continuous series of tissue stimulating pulses to output amplifier 3. The reset for counter 2 after each pulse occurs via OR gate 4, and monostable 6. The counter 2 is reset on the trailing edge of the monostable pulse and the firing time of the latter thus determines the pulse width of each stimulating pulse issued by counter 2.
  • Each reset pulse provided by monostable 6 also resets flip-flop 13, holding its Q output high. This reset holds until flip-flop 13 is clocked by a clock pulse CK 2 . Until this clocking occurs, the Q output of flip-flop 13 holds a reset on flip-flop 11.
  • the purpose of flip-flop 13 is to create a refractory period of 320 msecs-a period of time after a pacemaker pulse or a natural beat during which any input to the pacemaker via input amplfier 8 has no effect on the pacemaker behavior.
  • counter 9, flip-flop 11 and associated circuitry are to allow a single pulse at the input amplifier 8 to reset counter 2 if the pulse occurs outside the refractory period.
  • the pacemaker acts in a normal demand mode-only issuing pacemaker pulses if a natural beat is missing.
  • Counter 2 recommences counting and until the count CK z is reached, the reset on flip-flop 11 will be held. On reaching CK z , flip-flop 13 clocks and its Q output goes low, removing the flip-flop 11 1 reset. This is the end of the refractory period. Since counter 9 is locked out, and point "A" is locked low, flip-flop 11 is not clocked and its Q output remains low.
  • a single input pulse is received during the last 89-96 msec of the refractory period, this effectively acts to extend the refractory period by up to 96 msec maximum, to provide a "system refractory period" of 416 msec maximum.
  • This "refractory period extension" may be beneficial to the pacemaker in that extraneous signals present towards the latter part of the refractory period are ignored (as being natural heart beats) and the chance of the pacemaker being inhibited by unwanted signals (e.g. a large T-wave from the heart) is reduced.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)

Description

    Technical field
  • This invention relates to implantable body function control apparatus and particularly, to body tissue stimulating devices in the form of cardiac pacemakers.
  • Background art
  • Pacemakers for generating artificial stimulating pulses for the heart, and which may or may not be implanted in the body, are well-known. Pacemakers can be classified into demand and non-demand types. A demand pacemaker only issues an artificial pulse if the heart does not produce its own satisfactory natural beat, whereas a non-demand pacemaker issues artifical stimulating pulses without regard to the presence or absence of a natural beat.
  • A demand pacemaker normally includes an input amplifier for receiving and amplifying electrical signals from the heart (which signals might result from either a natural beat or an artificial pulse which has just been generated by the pacemaker), a pacemaker control circuitry which receives the amplified signals and which causes a new artificial stimulating pulse to be generated (for transmission to the heart) only if the amplified signals, or lack thereof, show that an artifical stimulating pulse is required by the heart (i.e. on demand), and an output amplifier which receives and amplifies the artifical pulses generated by the control circuitry, for passage to the heart.
  • Many types of pacemaker control circuitry as described above are available. Some function on an analog basis to produce the accurately- timed artifical stimulating pulses, whereas several recent designs employ digital circuitry.
  • With demand pacemakers, it is highly desirable to provide protection from the input circuitry from noise. Should a person bearing an implanted demand pacemaker meet an environment of high electrical noise, this noise may be picked up by the input amplifier which may then be incapable of distinguishing the picked-up signals from the signals it normally receives from the heart. In such circumstances, the circuitry is likely to consider the noise signals in the same manner as if it had received signals arising from a natural heart beat,-it will operate in its usual demand mode by not issuing artifical stimulating pulses to the heart. Since the heart may not be operating normally, and may indeed require artifical stimulation, these noise signals preventing such stimulation can lead to a dangerous condition for the person concerned.
  • Noise protection circuits have been incorporated into demand pacemakers in the past. For example, several include filters to attenuate noise signals of particular frequencies (particularly the commercial power mains frequency).
  • For example, one cardiac pacer affording a form of noise protection is known from French Patent Publication No. 2,329,007. This discloses a cardiac pacer wherein certain parameters including the refractory period and the mode of operation (fixed or demand) are controllable from an external circuit. Protection is afforded against adjustment of the pacer by noise signals. However, this protection only extends to noise signals received within the refractory period. If a disturbance signal with pulse intervals below a predetermined minimum interval commences after the end of the refractory period this is liable to erroneous evaluation as a signal arising due to the unaided action of the heart.
  • U.S. Patent No. 3,557,796 discloses a cardiac pacer in which a counter driven by an oscillator can be reset under certain conditions by ventricular or atrial input signals. Noise signals are detected before the period during which the pacer is sensitive to said input signals and, if such noise signals are detected, bring a noise protection circuit into operation. However, if a disturbance signal is initiated only very shortly before the sensitive period of the pacer, the number of noise pulses required for triggering the noise protection circuit is not attained.
  • Disclosure of invention
  • We have now developed a novel noise protection circuit for use in protecting demand pacemakers and which can be efficiently constructed with a small number of components of digital function. This is particularly useful in that it enables the components to be included in an integrated pacemaker circuit, e.g. of MSI or LSI construction.
  • According to the invention there is provided a demand cardiac stimulating apparatus comprising:
    • (a) oscillator means (1),
    • (b) first counter means (2), responsive to said oscillator means, for defining respectively increasing predetermined first, second and third count intervals, said first counter means being reset upon each achievement of said third count interval thereby to provide operation in a fixed rate mode, and being resettable independently of said counts at any time completely to reinitiate its full counting sequence thereby to provide operation in a demand mode;
    • (c) output amplifier means (3) for generating a stimulating pulse upon each achievement by said first counter means of said third count interval (CK3);
    • (d) input amplifier means (8) for sensing signals at the heart; characterised by:
    • (e) second counter means (9), controllably incrementable upon each repetition by said first counter means of said first count interval (CK1), said second counter means being reset to recommence counting by each signal sensed at the heart by said input amplifier means;
    • (f) first control means (13), responsive to first achievement by said first counter means, after resetting thereof, of said second count interval (CK2), said first control means establishing a refractory period for said stimulating apparatus after each resetting of said first counter means and otherwise independently of the state of said second counter means; and
    • (g) gating means (10), responsive to a predetermined count of said second counter means, and second control means (11) inhibited by said first control means during said refractory period and thereafter being energized by said gating means for resetting said first counter means and thereby providing suppression of demand stimulation in response to sensed signals having periodicity of less than the interval defined by said predetermined count of said second counter means, and causing reversion to operation in the fixed rate mode.
    Brief description of the drawings
  • Preferred features of the invention are illustrated in the accompanying drawings, in which:
    • Figure 1 shows a schematic electrical circuit diagram of an implantable, demand fixed-rate cardiac pacemaker according to the invention, and
    • Figure 2 is a timing diagram for use with Figure 1.
    Best mode of carrying out the invention
  • Referring to Figure 1, the pacemaker comprises an oscillator 1 which clocks a ripple counter 2. A cardiac stimulating pulse rate is obtained from an approriate output stage, Q, of counter 2 and is provided to an output amplifier 3 and to one input of an OR gate 4. The output amplifier 3 provides amplified tissue stimulating pulses to a connection 5 for coupling to an electrode leading to the heart. The output of OR gate 4 is supplied to a monostable 6, which is employed to reset counter 2.
  • The pacemaker also includes an input amplifier 8 which receives electrical signals generated at the heart (e.g. arising from natural heart beats) and supplies these signals, amplified, to the reset input of a ripple counter 9.
  • Two of the output stages of counter 9, nominated 03 and Q4 provide inputs to a NAND gate 10, the output of which supplies the clock input to a D-type flip-flop 11 and an input to a NAND gate 12. The latter clocks ripple counter 9.
  • The Q output of flip-flop 11 supplies a second input to OR gate 4, and the D-input of flip-flop 11 is tied to the positive supply rail.
  • A further D-type flip-flop 13 is provided which is reset from the output monostable 6 and whose Q output is employed to reset flip-flop 11. The D-input of flip-flop 13 is tied to the positive supply rail.
  • The counter 2 also supplies two clock outputs, CK, and CKz. CK,, having a period of 8 msecs, is employed to provide a second input to NAND gate 12, and CK2 is employed to clock flip-flop 13. The clock pulse CK2 arises 320 msecs after counter 2 is reset.
  • The pacemaker operates as follows. In its fixed rate mode, with neither noise nor natural heart beats being detected and amplified by input amplifier 8, counter 2 issues a continuous series of tissue stimulating pulses to output amplifier 3. The reset for counter 2 after each pulse occurs via OR gate 4, and monostable 6. The counter 2 is reset on the trailing edge of the monostable pulse and the firing time of the latter thus determines the pulse width of each stimulating pulse issued by counter 2.
  • Each reset pulse provided by monostable 6 also resets flip-flop 13, holding its Q output high. This reset holds until flip-flop 13 is clocked by a clock pulse CK2. Until this clocking occurs, the Q output of flip-flop 13 holds a reset on flip-flop 11. The purpose of flip-flop 13 is to create a refractory period of 320 msecs-a period of time after a pacemaker pulse or a natural beat during which any input to the pacemaker via input amplfier 8 has no effect on the pacemaker behavior.
  • The purpose of counter 9, flip-flop 11 and associated circuitry is to allow a single pulse at the input amplifier 8 to reset counter 2 if the pulse occurs outside the refractory period. In such a circumstance, the pacemaker acts in a normal demand mode-only issuing pacemaker pulses if a natural beat is missing.
  • For explanation of the normal demand mode operation, assume initially that counter 2 has issued a pulse to cause itself to reset via OR gate 4. This reset will have reset flip-flop 13 and this, via the Q output of the latter, will also reset flip-flop 11. The Q output of flip-flop 11 will be low. Assume also that counter 9 is full, in the sense that the Q3, Q4 stages are high. This will cause point "A" to be low, and the output of NAND gate 12 to be high, thus locking out further CK, clock pulses to counter 9.
  • Counter 2 recommences counting and until the count CKz is reached, the reset on flip-flop 11 will be held. On reaching CKz, flip-flop 13 clocks and its Q output goes low, removing the flip-flop 11 1 reset. This is the end of the refractory period. Since counter 9 is locked out, and point "A" is locked low, flip-flop 11 is not clocked and its Q output remains low.
  • If a single input pulse is received by amplifier 8 after the end of the refractory period (i.e. as a result of a natural heart beat), counter 9 is reset, Q3 and Q4 go low, and the point "A"' goes high to clock flip-flop 11. The Q output of the latter resets counter 2 via OR gate 4 to inhibit the pacemaker pulse being generated, and recommences the refractory period by resetting flip-flop 13. Counter 9, in the meantime, commences counting clock pulses CK, and locks out again when Q3, Q4 go high. It is of no consequence if the reset to counter 2 initiated by a natural heart beat arrives just as an artifical pulse is generated, since the natural beat and the stimulating pulse will essentially coincide.
  • If a series of input pulses are received having an interpulse period less than 88 msecs, counter 9 is continuously reset and, apart from the initial reset on the first of these pulses, point "A" does not make the low to high transition necessary to clock flip-flop 11. When this occurs, flip-flop 11 is then incapable of continuously resetting counter and the pacemaker reverts to the fixed rate mode described above. The effect of the noise protection circuitry is hence to cause the pacemaker to operate in its fixed rate, non-demand mode in the presence of noise (or heart generated signals) having a period less than 88 msec. This figure of 88 msec arises in that it is the minimum time required to fill counter 9 (i.e. Q3 and Q4 high) after a first input pulse is received via amplifier 8 to reset counter 9. The maximum time required to fill counter 9 is 96 msec. The spread of 88 to 96 msec (1 clock period) is due to the asynchronous nature of the incoming signal to amplifier 8 compared to the next occurrence of a CK, clock pulse.
  • If a single input pulse is received during the last 89-96 msec of the refractory period, this effectively acts to extend the refractory period by up to 96 msec maximum, to provide a "system refractory period" of 416 msec maximum. This "refractory period extension" may be beneficial to the pacemaker in that extraneous signals present towards the latter part of the refractory period are ignored (as being natural heart beats) and the chance of the pacemaker being inhibited by unwanted signals (e.g. a large T-wave from the heart) is reduced.
  • This phenomenon of "refractory period extension" is best understood with reference to the timing diagram of Figure 2. A reset to counter 9 arises towards the end of the refractory period and this sends the point "A" (clock input to flip-flop 11) high. The period for which "A" remains high after the refractory period of 320 msec expires (a maximum of 96 msecs) acts as a "refractory period extension". Any input to amplifier 8 causing a reset on counter 9 during this extended period (the "system refractory period") will not inhibit the count being generated by the counter 2.

Claims (3)

1. Demand cardiac stimulating apparatus comprising:
(a) oscillator means (1);
(b) first counter means (2), responsive to said oscillator means, for defining respectively increasing predetermined first, second and third counter intervals, said first counter means being reset upon each achievement of said third counter interval thereby to provide operation in a fixed rate mode, and being resettable independently of said counts at any time completely to reinitiate its full counting sequence thereby to provide operation in a demand mode.
(c) output amplifier means (3) for generating a stimulating pulse upon each achievement by said first counter means of said third count interval (CK3);
(d) input amplifier means (8) for sensing signals at the heart;
characterised by:
(e) second counter means (9), controllably incrementable upon each repetition by said first counter means of said first counter interval (CK1), said second counter means being reset to recommence counting by each signal sensed at the heart by said input amplifier means;
(f) first control means (13), responsive to first achievement by said first counter means, after resetting thereof, of said second count interval (CK2), said first control means establishing a refractory period for said stimulating apparatus after each resetting of said first counter means and otherwise independently of the state of said second counter means; and
(g) gating means (10), responsive to a predetermined count of said second counter means and second control means (11) inhibited by said first control means during said refractory period and thereafter being energized by said gating means for resetting said first counter means and thereby providing suppression of demand stimulation in response to sensed signals having periodicity of less than the interval defined by said predetermined count of said second counter means, and causing reversion to operation in the fixed rate mode.
2. An apparatus according to claim 1 characterised in that said first control means (13) comprises a D-type flip-flop having its D-input maintained at a logic 1 state, its reset input (R) connected to the reset input (R) of said first counter means (2), its clock input (CK) controlled by said second count interval (CK2) of said first counter means (2), and its Q output providing control for said second control means (11).
3. An apparatus according to claim 2 characterized in that said second control means (11) comprises a D-type flip-flop having its D-input maintained at a 12pic 1 state, its reset input (R) coupled to said Q output of said first control means (13), its clock input (CK) controlled by said gating means (10), and its Q output coupled to reset said first counter means (2).
EP19780300242 1977-08-19 1978-08-03 Demand cardiac stimulating apparatus Expired EP0000988B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB3491477 1977-08-19
GB3491477 1977-08-19
US917129 1978-06-19
US05/917,129 US4173230A (en) 1977-08-19 1978-06-19 Noise elimination and refractory period control in demand pacers

Publications (2)

Publication Number Publication Date
EP0000988A1 EP0000988A1 (en) 1979-03-07
EP0000988B1 true EP0000988B1 (en) 1982-05-26

Family

ID=26262490

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19780300242 Expired EP0000988B1 (en) 1977-08-19 1978-08-03 Demand cardiac stimulating apparatus

Country Status (4)

Country Link
EP (1) EP0000988B1 (en)
AU (1) AU3895978A (en)
CA (1) CA1098589A (en)
DE (1) DE2861865D1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440198A1 (en) * 1978-11-06 1980-05-30 Medtronic Inc IMPLANTABLE STIMULATOR
US4236522A (en) * 1978-11-06 1980-12-02 Medtronic, Inc. Asynchronous/demand made programmable digital cardiac pacemaker
US4250883A (en) * 1978-11-06 1981-02-17 Medtronic, Inc. Digital cardiac pacemaker with refractory, reversion and sense reset means

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557796A (en) * 1969-03-10 1971-01-26 Cordis Corp Digital counter driven pacer
US4049003A (en) * 1975-10-23 1977-09-20 Arco Medical Products Company Digital cardiac pacer
NL7700427A (en) * 1976-03-03 1977-09-06 Arco Med Prod Co PLANTABLE DIGITAL PASSENGER WHICH IS FITTED WITH EXTERNALLY SELECTABLE BUSINESS PARAMETERS.

Also Published As

Publication number Publication date
EP0000988A1 (en) 1979-03-07
AU3895978A (en) 1980-02-21
DE2861865D1 (en) 1982-07-15
CA1098589A (en) 1981-03-31

Similar Documents

Publication Publication Date Title
US4407287A (en) Atrial and ventricular-only pacemaker responsive to premature ventricular contractions
CA1229882A (en) Constant a-a interval control for dvi and ddd cardiac pacemakers
US4401119A (en) Prolongation of timing intervals in response to ectopic heart beats in atrial and ventricular pacemakers
US5501701A (en) Pacemaker with vasovagal syncope detection and therapy
US5441525A (en) Pacemaker with vasovagal syncope detection
US3949758A (en) Automatic threshold following cardiac pacer
US4343311A (en) Atrial refractory control for R-wave rejection in pacemakers
US4788980A (en) Pacemaker having PVC response and PMT terminating features
US4408606A (en) Rate related tachycardia control pacer
US4827934A (en) Sensing margin detectors for implantable electromedical devices
US4363325A (en) Mode adaptive pacer
EP0423600A2 (en) Automatically adjustable blanking period for implantable pacemaker
GB2129687A (en) Duel chamber pacer
US4173230A (en) Noise elimination and refractory period control in demand pacers
US4649931A (en) Sampled data sense amplifier
US4170999A (en) Demand pacer having reduced recovery time
EP0050038B1 (en) Heart pacemaker with separate a-v intervals for atrial synchronous and atrial-ventricular sequential pacing modes
EP0011942A2 (en) Programmable cardiac pacemaker
GB2048688A (en) Programmable demand pacer
US3757791A (en) Synchronized atrial and ventricular pacer and timing circuitry therefor
US4304238A (en) Programmable demand pacer
US4802483A (en) Heart pacemaker for avoiding pacemaker mediated tachycardia at mode switching
CA1106450A (en) Digital cardiac pacer with refractory count inhibition
EP0000988B1 (en) Demand cardiac stimulating apparatus
CA1101935A (en) Digital cardiac pacer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): DE FR GB NL SE

17P Request for examination filed
GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): DE FR GB NL SE

REF Corresponds to:

Ref document number: 2861865

Country of ref document: DE

Date of ref document: 19820715

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19830731

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19840804

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19840828

Year of fee payment: 7

GBPC Gb: european patent ceased through non-payment of renewal fee
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19860831

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19880301

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19880429

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19881117

EUG Se: european patent has lapsed

Ref document number: 78300242.1

Effective date: 19850612

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19971028

Year of fee payment: 20

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT